These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 20092510)

  • 1. Peripheral opioid antagonism.
    Mehta V
    Anaesthesia; 2009 Dec; 64(12):1279-82. PubMed ID: 20092510
    [No Abstract]   [Full Text] [Related]  

  • 2. Opioid antagonists for prevention and treatment of opioid-induced gastrointestinal effects.
    Holzer P
    Curr Opin Anaesthesiol; 2010 Oct; 23(5):616-22. PubMed ID: 20543677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADL 8-2698, a trans-3,4-dimethyl-4-(3-hydroxyphenyl) piperidine, prevents gastrointestinal effects of intravenous morphine without affecting analgesia.
    Liu SS; Hodgson PS; Carpenter RL; Fricke JR
    Clin Pharmacol Ther; 2001 Jan; 69(1):66-71. PubMed ID: 11180040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged apnea after remifentanil.
    Nelson RY; Bretz B; Egan TD
    J Clin Anesth; 2007 Feb; 19(1):60-3. PubMed ID: 17321930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidural naloxone reduces intestinal hypomotility but not analgesia of epidural morphine.
    Lee J; Shim JY; Choi JH; Kim ES; Kwon OK; Moon DE; Choi JH; Bishop MJ
    Can J Anaesth; 2001 Jan; 48(1):54-8. PubMed ID: 11212050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid-induced bowel dysfunction.
    Thomas J
    J Pain Symptom Manage; 2008 Jan; 35(1):103-13. PubMed ID: 17981003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tolerated opioid therapy with oxycodone/naloxone. Better quality of life for osteoporosis patients].
    MMW Fortschr Med; 2009 Apr; 151(18):27. PubMed ID: 19769067
    [No Abstract]   [Full Text] [Related]  

  • 8. [Respiratory depression after postoperative analgesia using remifentanil].
    Calderón E; de Antonio P; Pernia A; García D; Calderón-Pla E; Torres LM
    Rev Esp Anestesiol Reanim; 1999; 46(6):272-3. PubMed ID: 10439650
    [No Abstract]   [Full Text] [Related]  

  • 9. Naloxegol (Movantik) for opioid-induced constipation.
    Med Lett Drugs Ther; 2015 Sep; 57(1478):135-7. PubMed ID: 26393826
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of naloxone on the breathing pattern of a newborn exposed to maternal opiates.
    van Vonderen JJ; Siew ML; Hooper SB; de Boer MA; Walther FJ; te Pas AB
    Acta Paediatr; 2012 Jul; 101(7):e309-12. PubMed ID: 22372574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid opioid detoxification under anaesthesia.
    Cook TM; Collins PD
    Hosp Med; 1998 Mar; 59(3):245-7. PubMed ID: 9722357
    [No Abstract]   [Full Text] [Related]  

  • 12. [Modern pain therapy with dual advantage. Strong analgesia and superior tolerance].
    MMW Fortschr Med; 2009 Apr; 151(18):26. PubMed ID: 19769066
    [No Abstract]   [Full Text] [Related]  

  • 13. Opioids causing a back up in the pediatric intensive care unit? No solution yet.
    Thomas NJ; Tamburro RF
    Pediatr Crit Care Med; 2006 May; 7(3):287-8. PubMed ID: 16682895
    [No Abstract]   [Full Text] [Related]  

  • 14. The diverse clinical uses of opioid receptor drugs.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2010 May; 48(5):11-4. PubMed ID: 20415289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose naloxone infusion for the treatment of intractable nausea and vomiting after intrathecal morphine in a parturient.
    Sposito JA; Habib AS
    Int J Obstet Anesth; 2010 Jan; 19(1):119-21. PubMed ID: 19945849
    [No Abstract]   [Full Text] [Related]  

  • 16. Transdermal fentanyl and respiratory depression.
    McLoughlin R; McQuillan R
    Palliat Med; 1997 Sep; 11(5):419. PubMed ID: 9472602
    [No Abstract]   [Full Text] [Related]  

  • 17. Optimal dose range of epidural naloxone to reduce nausea in patients receiving epidural morphine.
    Kim ES; Lee J; Choi JH
    Can J Anaesth; 2004 Dec; 51(10):1048-9. PubMed ID: 15574562
    [No Abstract]   [Full Text] [Related]  

  • 18. Comments on reducing the health consequences of opioid addiction.
    Keller DL
    Am J Med; 2013 Nov; 126(11):e19. PubMed ID: 24157294
    [No Abstract]   [Full Text] [Related]  

  • 19. The reply.
    Bruce RD; Beletsky L; Stancliff S
    Am J Med; 2013 Nov; 126(11):e17. PubMed ID: 24157293
    [No Abstract]   [Full Text] [Related]  

  • 20. The reply.
    Bruce RD; Beletsky L; Stancliff S; Bowman S
    Am J Med; 2013 Nov; 126(11):e21-2. PubMed ID: 24157295
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.